Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles

Fertility and Sterility

Volumn 94, Issue 4, 2010, Pages 1350-1355

  Younis, Johnny S ^a,b   Soltsman, Sofia ^a   Izhaki, Ido ^c   Radin, Orit ^a   Bar Ami, Shalom ^a   Ben Ami, Moshe ^a,b  

^a Poriya Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

follicular recruitment; GnRH antagonist; oocyte competence; oocyte meiotic status

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GANIRELIX; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; GONADORELIN; HORMONE ANTAGONIST;

ARTICLE; CELL DIVISION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; ENDOMETRIUM; ESTROGEN BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEIOSIS; MENSTRUAL CYCLE; OOCYTE; OUTCOME ASSESSMENT; OVARY FOLLICLE; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT DURATION; ADULT; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG ADMINISTRATION; DRUG EFFECTS; FOLLICULAR PHASE; OOCYTE RETRIEVAL; PREGNANCY; PROCEDURES; QUALITY CONTROL; TIME;

ADULT; DRUG ADMINISTRATION SCHEDULE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MEIOSIS; OOCYTE RETRIEVAL; OOCYTES; PREGNANCY; QUALITY CONTROL; TIME FACTORS;

EID: 77956188850     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.08.033     Document Type: Article

References (20)

1. H.G. Al-Inany, A.M. Abou-Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception Cochrane Database Syst Rev 3 2006 CD001750
2. B.C. Fauser, and P. Devroey Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril 83 2005 1607 1611
3. G. Griesinger, R. Felberbaum, and K. Diedrich GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry Hum Reprod 20 2005 2373 2375
4. M. Ludwig, A. Katalinic, C. Banz, A.K. Schroder, M. Loning, and J.M. Weiss Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study Hum Reprod 17 2002 2842 2845
5. J.L. Hwang, K.M. Seow, Y.H. Lin, L.W. Huang, B.C. Hsieh, and Y.L. Tsai Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study Hum Reprod 19 2004 1993 2000
6. T. Lainas, J. Zorzovilis, G. Petsas, G. Stavropoulou, H. Cazlaris, and V. Daskalaki In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF Hum Reprod 20 2005 2426 2433
7. E.M. Kolibianakis, C. Albano, M. Camus, H. Tournaye, A.C. Van Steirteghem, and P. Devoroey Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles J Clin Endocrinol Metab 88 2003 5632 5637
8. R. Fanchin, L. Salomon, A. Castelo-Branco, F. Olivennes, N. Frydman, and R. Frydman Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists Hum Reprod 18 2003 2698 2703
9. R. Fanchin, A. Castelo Branco, I.J. Kadoch, G. Hosny, M. Bagirova, and R. Frydman Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation Fertile Steril 81 2004 1554 1559
10. J.J. Oberye, B.M. Mannaerts, J.A. Huisman, and C.J. Timmer Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers Fertil Steril 72 1999 1006 1012
11. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
12. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
13. J.S. Younis, O. Radin, N. Mirsky, I. Izhaki, T. Majara, and S. Bar-ami First polar body and nucleolar precursor body morphology is related to the ovarian reserve of infertile women Reprod Biomed Online 16 2008 851 858
14. A.C. Van Steirteghem, Z. Nagy, H. Joris, J. Liu, C. Staessen, and J. Smitz High fertilization and implantation rates after intracytoplasmic sperm injection Hum Reprod 8 1993 1061 1066
15. L.L. Veeck Atlas of the human oocyte and early conceptus Vol. 2 1991 Williams & Wilkins Baltimore, MD 121-246
16. J.W. Lens, and P.M. Rijnders M. Bras, J.W. Lens, M.H. Piederiet, M.P. Rijnders, M. Verveld, G.H. Zeilmaker, Laboratory aspects of in-vitro fertilization 1996 The embryo/practice N. V. Organon Oss, Netherlands 177 203
17. J.A. Huirne, R. Homburg, and C.B. Lambalk Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 22 2007 2805 2813
18. K.E. Elkind-Hirsch, B.W. Webster, C.P. Brown, and M.W. Vernon Concurrent ganirelix and follitropin β-therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome Fertil Steril 79 2003 603 607
19. E.M. Kolibianakis, C. Zikopoulos, J. Smitz, M. Camus, H. Tournaye, and A.C. Van Steirteghem Administration of GnRH antagonist from day 1 of stimulation in in vitro fertilization Fertil Steril 82 2004 223 226
20. L.G. Westergaard, S.B. Laursen, and C.Y. Andersen Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction Hum Reprod 15 2000 1003 1008